Empa M combines empagliflozin, an SGLT2 inhibitor, with metformin, a biguanide antidiabetic medicine.
This dual-action combination helps lower blood glucose by increasing urinary glucose excretion, reducing hepatic glucose production, and improving insulin sensitivity.
Empagliflozin has also demonstrated cardiovascular and renal benefits in appropriate patients.
Treatment should be combined with diet, exercise, and regular monitoring.
Uses
- Type 2 diabetes mellitus
Active Ingredients
- Empagliflozin 12.5mg
- Metformin Hydrochloride 1000mg
How to Take
- Take with meals exactly as prescribed by your healthcare provider.
Precautions
- Prescription-only medicine.
- Monitor kidney function regularly.
- Maintain adequate hydration.
- Seek urgent medical attention if symptoms of ketoacidosis or lactic acidosis develop.
